Amodiaquine plus artesunate versus dihydroartemisinin-piperaquine for drug resistant P.falciparum and P.vivax in Papua, Indonesia

Amodiaquine plus artesunate versus dihydroartemisinin-piperaquine for drug resistant P.falciparum and P.vivax in Papua, Indonesia

Bibliographic Details
Main Authors:	Armedy, R, Hotma, L, Kanagalem, E, Rumaseuw, R, Ebsworth, E, Anstey, N, Tjitra, E, Price, R
Format:	Journal article
Published:	2006

Similar Items

HEMATOLOGICAL CHANGES IN P.FALCIPARUM & P.VIVAX MALARIA
by: Ameekumari Patel, et al.
Published: (2013-03-01)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
by: Hasugian, A, et al.
Published: (2007)

A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
by: Pasaribu, A, et al.
Published: (2013)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
by: Armedy Ronny Hasugian, et al.
Published: (2016-03-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
by: Armedy Ronny Hasugian, et al.
Published: (2016-03-01)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
by: Poespoprodjo, JR, et al.
Published: (2014)

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.
by: Price, R, et al.
Published: (2007)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
by: Hadjar Siswantoro, et al.
Published: (2015-01-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
by: Hadjar Siswantoro, et al.
Published: (2015-01-01)

Therapeutic response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax nine years after its introduction in Southern Papua, Indonesia
by: Poespoprodjo, JR, et al.
Published: (2018)

Alternative treatment options for chloroquine resistant Plasmodium vivax in Papua, Indonesia
by: Price, R, et al.
Published: (2005)

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
by: Poespoprodjo, J, et al.
Published: (2015)

The impact of intermittent preventive treatment in school aged children with dihydroartemisinin piperaquine and artesunate amodiaquine on IgG response against six blood stage Plasmodium falciparum antigens.
by: Eric Lyimo, et al.
Published: (2025-01-01)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
by: Byakika-Kibwika, P, et al.
Published: (2019)

Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
by: Karol Marwa, et al.
Published: (2022-01-01)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
by: Ashenafi Assefa, et al.
Published: (2022-12-01)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia
by: Valecha, N, et al.
Published: (2010)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
by: Valecha, N, et al.
Published: (2010)

Efficacy and safety of dihydroartemisinin-piperaquine.
by: Myint, H, et al.
Published: (2007)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
by: Ashenaf Assefa, et al.
Published: (2023-04-01)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
by: Smithuis, F, et al.
Published: (2006)

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
by: Neena Valecha, et al.
Published: (2010-01-01)

Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection—a case report
by: Sonali Prasad, et al.
Published: (2022-10-01)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
by: Phyo, A, et al.
Published: (2011)

Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
by: Zongo, I, et al.
Published: (2015)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
Published: (2010-01-01)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
Published: (2010-01-01)

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated <it>Plasmodium falciparum</it> malaria in India
by: Gargano Nicola, et al.
Published: (2012-07-01)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia.
by: Neena Valecha, et al.
Published: (2010-01-01)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia.
by: Neena Valecha, et al.
Published: (2010-01-01)

Comparative Studies On Response To 5-Day Treatment With Primaquine Of Indigenous & Imported Cases Of P.Vivax in Nepal in 1974-76
by: A V Kondrashin, et al.
Published: (2013-04-01)

A randomized comparison of chloroquine versus dihydroartemisinin-piperaquine for the treatment of Plasmodium vivax infection in Vietnam
by: Thuan, PD, et al.
Published: (2016)

A randomized comparison of Chloroquine versus Dihydroartemisinin-Piperaquine for the treatment of Plasmodium vivax infection in Vietnam
by: Thuan, P, et al.
Published: (2016)

Therapeutic and Transmission-Blocking  Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
by: Jean Popovici, et al.
Published: (2018-08-01)

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
by: Hasugian, A, et al.
Published: (2009)

Population pharmacokinetics of artesunate and amodiaquine in African children.
by: Stepniewska, K, et al.
Published: (2009)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
by: Awab, G, et al.
Published: (2010)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
by: Woodrow Charles J, et al.
Published: (2010-04-01)

Efficacy and safety of dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Papua and Sumatra, Indonesia
by: Puji B. S. Asih, et al.
Published: (2022-03-01)

Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
by: Steve M Taylor, et al.
Published: (2022-10-01)